{"version":"1.0","type":"link","title":"Prognostic Value of F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.","author_name":"Kocaaslan E 외","author_url":"https://prs-insight.online/author/Kocaaslan%20E","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98494","thumbnail_width":1200,"thumbnail_height":630}